In our study, the strong mechanism provided and the observation that sortilin, ASM, S1P, and sNOX2-dp level increases were more pronounced in uncontrolled hypertensive patients add new clinical perspectives for future development of multiple biomarker-based approaches, aiming at improving the ability to predict and monitor the progression of hypertension. The gene discussed is SMPD1; the disease is hypertensive disorder.